Catalyst Pharmaceuticals (CPRX) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.17% |
| Dec 31, 2025 | -37.02% |
| Sep 30, 2025 | -55.97% |
| Jun 30, 2025 | -73.76% |
| Mar 31, 2025 | -87.06% |
| Dec 31, 2024 | -276.03% |
| Sep 30, 2024 | -265.65% |
| Jun 30, 2024 | -110.13% |
| Mar 31, 2024 | -109.39% |
| Dec 31, 2023 | 53.87% |
| Sep 30, 2023 | 52.76% |
| Jun 30, 2023 | 19.02% |
| Mar 31, 2023 | 25.05% |
| Dec 31, 2022 | -56.01% |
| Sep 30, 2022 | -46.50% |
| Jun 30, 2022 | -42.19% |
| Mar 31, 2022 | -38.03% |
| Dec 31, 2021 | -36.35% |
| Sep 30, 2021 | -37.51% |
| Jun 30, 2021 | -34.96% |
| Mar 31, 2021 | -40.83% |
| Dec 31, 2020 | -48.41% |
| Sep 30, 2020 | -66.06% |
| Jun 30, 2020 | -92.01% |
| Mar 31, 2020 | -122.98% |
| Dec 31, 2019 | -76.73% |
| Sep 30, 2019 | -24.13% |
| Jun 30, 2019 | 12.41% |
| Mar 31, 2019 | 41.45% |
| Dec 31, 2018 | 36.34% |
| Sep 30, 2018 | -81.87% |
| Jun 30, 2018 | -94.72% |
| Mar 31, 2018 | -113.39% |
| Dec 31, 2017 | -107.92% |
| Sep 30, 2017 | -86.24% |
| Jun 30, 2017 | 22.37% |
| Mar 31, 2017 | -40.78% |
| Dec 31, 2016 | -26.46% |
| Sep 30, 2016 | 50.08% |
| Jun 30, 2016 | -10.54% |
| Mar 31, 2016 | 42.39% |
| Dec 31, 2015 | 10.14% |
| Sep 30, 2015 | 3.35% |
| Jun 30, 2015 | -121.10% |
| Mar 31, 2015 | -841.18% |
| Dec 31, 2014 | -80.52% |
| Sep 30, 2014 | -59.61% |
| Jun 30, 2014 | -151.52% |
| Mar 31, 2014 | -640.73% |
| Dec 31, 2013 | -120.98% |
| Sep 30, 2013 | -97.44% |
| Jun 30, 2013 | 2.04% |
| Mar 31, 2013 | 86.32% |
| Dec 31, 2012 | -47.86% |
| Sep 30, 2012 | -188.17% |
| Jun 30, 2012 | -38.96% |
| Mar 31, 2012 | 31.28% |
| Dec 31, 2011 | -10.12% |
| Sep 30, 2011 | 33.49% |